Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,386 public trials 160 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Recruiting

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

NCT07218510

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
  • University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States
View Trial Details
Recruiting

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

NCT06059391

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +34 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • DFCI/BWH Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

NCT05544019

Conditions
ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations
  • Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
  • Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
  • Napa Research Pompano Beach, Florida, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Recruiting

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

NCT04895436

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 230157 La Jolla, California, United States
  • Winship Cancer Institute of Emory University /ID# 230643 Atlanta, Georgia, United States
  • Des Moines Oncology Research Association /ID# 232606 Des Moines, Iowa, United States
  • Dana-Farber Cancer Institute /ID# 230061 Boston, Massachusetts, United States
View all 58 locations
View Trial Details

Related conditions